Evidence map›Paper›PMID 30123125›Full record

ArticleFrontiers in pharmacology2018

Oral Administration of

Jixue Zhao, Degang Ji, Xujie Zhai, Lirong Zhang, Xiao Luo, Xin Fu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  6. Article
  7. AnHeliyon · 2022
    Article
  8. Review
  9. Emerging therapeutic role ofChinese herbal medicines · 2022
    Review
  10. Water-ExtractedFrontiers in pharmacology · 2022
    Article
  11. The Antitumour Effect ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jixue ZhaoDepartment of Pediatric Surgery, The First Hospital of Jilin University, Changchun, China.
Degang JiDepartment of Hepatobiliary Pancreatic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Xujie ZhaiDepartment of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Lirong ZhangDepartment of Pathology, China-Japan Union Hospital of Jilin University, Changchun, China.
Xiao LuoDepartment of Breast Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Xin FuDepartment of Nursing, China-Japan Union Hospital of Jilin University, Changchun, China.
Jilin University · CNFirst Hospital of Jilin University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to explore the efficacy and safety of

Indexed as

breast cancerdisease-free survivalpathologic complete responsePVLside effectstaxanes

Identifiers

PMID30123125
PMCPMC6085460
OpenAlexW2885127642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.